244 related articles for article (PubMed ID: 22492235)
1. Identification of functional elements of the GDP-fucose transporter SLC35C1 using a novel Chinese hamster ovary mutant.
Zhang P; Haryadi R; Chan KF; Teo G; Goh J; Pereira NA; Feng H; Song Z
Glycobiology; 2012 Jul; 22(7):897-911. PubMed ID: 22492235
[TBL] [Abstract][Full Text] [Related]
2. CHO-gmt5, a novel CHO glycosylation mutant for producing afucosylated and asialylated recombinant antibodies.
Haryadi R; Zhang P; Chan KF; Song Z
Bioengineered; 2013; 4(2):90-4. PubMed ID: 22989990
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of GDP-fucose transporter gene (Slc35c1) in CHO cells by ZFNs, TALENs and CRISPR-Cas9 for production of fucose-free antibodies.
Chan KF; Shahreel W; Wan C; Teo G; Hayati N; Tay SJ; Tong WH; Yang Y; Rudd PM; Zhang P; Song Z
Biotechnol J; 2016 Mar; 11(3):399-414. PubMed ID: 26471004
[TBL] [Abstract][Full Text] [Related]
4. Amino acid residues important for CMP-sialic acid recognition by the CMP-sialic acid transporter: analysis of the substrate specificity of UDP-galactose/CMP-sialic acid transporter chimeras.
Takeshima-Futagami T; Sakaguchi M; Uehara E; Aoki K; Ishida N; Sanai Y; Sugahara Y; Kawakita M
Glycobiology; 2012 Dec; 22(12):1731-40. PubMed ID: 22833315
[TBL] [Abstract][Full Text] [Related]
5. Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells.
Wong NS; Yap MG; Wang DI
Biotechnol Bioeng; 2006 Apr; 93(5):1005-16. PubMed ID: 16432895
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of UDP-GlcNAc transporter partially corrects galactosylation defect caused by UDP-Gal transporter mutation.
Maszczak-Seneczko D; Olczak T; Jakimowicz P; Olczak M
FEBS Lett; 2011 Oct; 585(19):3090-4. PubMed ID: 21889501
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics.
Kanda Y; Imai-Nishiya H; Kuni-Kamochi R; Mori K; Inoue M; Kitajima-Miyama K; Okazaki A; Iida S; Shitara K; Satoh M
J Biotechnol; 2007 Jun; 130(3):300-10. PubMed ID: 17559959
[TBL] [Abstract][Full Text] [Related]
8. Decrease in antithrombin III fucosylation by expressing GDP-fucose transporter siRNA in Chinese hamster ovary cells.
Omasa T; Tanaka R; Doi T; Ando M; Kitamoto Y; Honda K; Kishimoto M; Ohtake H
J Biosci Bioeng; 2008 Aug; 106(2):168-73. PubMed ID: 18804060
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of fucose into glycans independent of the GDP-fucose transporter SLC35C1 preferentially utilizes salvaged over de novo GDP-fucose.
Skurska E; Szulc B; Maszczak-Seneczko D; Wiktor M; Wiertelak W; Makowiecka A; Olczak M
J Biol Chem; 2022 Aug; 298(8):102206. PubMed ID: 35772493
[TBL] [Abstract][Full Text] [Related]
10. In vivo evidence for GDP-fucose transport in the absence of transporter SLC35C1 and putative transporter SLC35C2.
Lu L; Varshney S; Yuan Y; Wei HX; Tanwar A; Sundaram S; Nauman M; Haltiwanger RS; Stanley P
J Biol Chem; 2023 Dec; 299(12):105406. PubMed ID: 38270391
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a mutation and an alternative splicing of UDP-galactose transporter in MDCK-RCAr cell line.
Olczak M; Guillen E
Biochim Biophys Acta; 2006 Jan; 1763(1):82-92. PubMed ID: 16434112
[TBL] [Abstract][Full Text] [Related]
12. Slc35c2 promotes Notch1 fucosylation and is required for optimal Notch signaling in mammalian cells.
Lu L; Hou X; Shi S; Körner C; Stanley P
J Biol Chem; 2010 Nov; 285(46):36245-54. PubMed ID: 20837470
[TBL] [Abstract][Full Text] [Related]
13. N-glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometry.
Otto VI; Damoc E; Cueni LN; Schürpf T; Frei R; Ali S; Callewaert N; Moise A; Leary JA; Folkers G; Przybylski M
Glycobiology; 2006 Nov; 16(11):1033-44. PubMed ID: 16877748
[TBL] [Abstract][Full Text] [Related]
14. Engineering novel Lec1 glycosylation mutants in CHO-DUKX cells: molecular insights and effector modulation of N-acetylglucosaminyltransferase I.
Zhong X; Cooley C; Seth N; Juo ZS; Presman E; Resendes N; Kumar R; Allen M; Mosyak L; Stahl M; Somers W; Kriz R
Biotechnol Bioeng; 2012 Jul; 109(7):1723-34. PubMed ID: 22252477
[TBL] [Abstract][Full Text] [Related]
15. A mutation causing a reduced level of expression of six beta4-galactosyltransferase genes is the basis of the Lec19 CHO glycosylation mutant.
Lee J; Park SH; Sundaram S; Raju TS; Shaper NL; Stanley P
Biochemistry; 2003 Oct; 42(42):12349-57. PubMed ID: 14567696
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of a human GDP-L-fucose transporter in Escherichia coli.
Förster-Fromme K; Schneider S; Sprenger GA; Albermann C
Biotechnol Lett; 2017 Feb; 39(2):219-226. PubMed ID: 27738779
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of human Golgi nucleotide sugar transporter SLC35D2, a novel member of the SLC35 nucleotide sugar transporter family.
Ishida N; Kuba T; Aoki K; Miyatake S; Kawakita M; Sanai Y
Genomics; 2005 Jan; 85(1):106-16. PubMed ID: 15607426
[TBL] [Abstract][Full Text] [Related]
18. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
Wright A; Morrison SL
J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of three gain-of-function CHO mutants that add the bisecting GlcNAc to N-glycans.
Stanley P; Sundaram S; Tang J; Shi S
Glycobiology; 2005 Jan; 15(1):43-53. PubMed ID: 15329358
[TBL] [Abstract][Full Text] [Related]
20. Substrate recognition by UDP-galactose and CMP-sialic acid transporters. Different sets of transmembrane helices are utilized for the specific recognition of UDP-galactose and CMP-sialic acid.
Aoki K; Ishida N; Kawakita M
J Biol Chem; 2001 Jun; 276(24):21555-61. PubMed ID: 11279205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
